| Preview | Issue Date | Title / Name | Author(s) | Type |
| 2020 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard H.; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
| Jan-2023 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
| 2019 | Consumer and clinician perspectives on personalising breast cancer prevention information | Keogh, L. A.; Steel, E.; Weideman, P.; Butow, P.; Collins, Ian M., et al | Journal Article | |
 | 2021 | Measuring the quality of cancer care in the Barwon South Western region, Victoria, Australia | Matheson, Leigh M.; Pitson, Graham; Yap, Cheng H.; Singh, Madhu; Collins, Ian M., et al | Journal Article | |
| 2020 | Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer | Conduit, C.; de Boer, R. H.; Lok, S.; Gibbs, Peter; Malik, Laeeq, et al | Journal Article | |
| Oct-2022 | Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study | Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Yeo, Belinda, et al | Journal Article | |
